glp 1 agonist for prediabetes Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus How GLP-1 Receptor Agonists Evolved
Description
Lifetime health effects and cost-effectiveness of tirzepatide and semaglutide in US adults
doi: 10.1056/NEJMoa2032183
For sublingual drops, an empty stomach is recommended but less critical since the medication absorbs through the mouth, not the stomach
Of patients taking GLP-1, 8.9% developed NAION compared to 1.8% of patients taking other medications
Kastin AJ, Akerstrom V
The American pharma company looks intent on closing the gap with Novo Nordisk and Eli Lilly, both of which have been dominating the global GLP-1 market for a while now
